The Cooper Companies, Inc. (NASDAQ:COO) Shares Acquired by Sumitomo Mitsui DS Asset Management Company Ltd

Sumitomo Mitsui DS Asset Management Company Ltd lifted its holdings in The Cooper Companies, Inc. (NASDAQ:COO) by 0.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 32,552 shares of the medical device company’s stock after buying an additional 198 shares during the period. Sumitomo Mitsui DS Asset Management Company Ltd’s holdings in Cooper Companies were worth $2,993,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also recently bought and sold shares of COO. Sumitomo Mitsui Trust Group Inc. grew its holdings in Cooper Companies by 1.7% in the 4th quarter. Sumitomo Mitsui Trust Group Inc. now owns 451,544 shares of the medical device company’s stock valued at $41,510,000 after buying an additional 7,681 shares in the last quarter. Bleakley Financial Group LLC grew its holdings in shares of Cooper Companies by 9.9% in the fourth quarter. Bleakley Financial Group LLC now owns 6,336 shares of the medical device company’s stock valued at $582,000 after purchasing an additional 569 shares during the period. Mirae Asset Global Investments Co. Ltd. increased its position in Cooper Companies by 27.6% during the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 22,749 shares of the medical device company’s stock worth $2,097,000 after purchasing an additional 4,916 shares during the last quarter. Mather Group LLC. increased its position in Cooper Companies by 7.4% during the fourth quarter. Mather Group LLC. now owns 1,926 shares of the medical device company’s stock worth $177,000 after purchasing an additional 133 shares during the last quarter. Finally, Alliance Wealth Advisors LLC UT raised its stake in Cooper Companies by 3.8% during the fourth quarter. Alliance Wealth Advisors LLC UT now owns 11,262 shares of the medical device company’s stock worth $1,035,000 after purchasing an additional 416 shares during the period. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of analysts have recently issued reports on the stock. Morgan Stanley cut their price target on shares of Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a report on Friday, December 6th. Citigroup cut their target price on Cooper Companies from $116.00 to $115.00 and set a “buy” rating for the company in a research note on Friday, December 6th. StockNews.com lowered Cooper Companies from a “buy” rating to a “hold” rating in a research note on Wednesday, December 11th. Wells Fargo & Company raised their price objective on Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a research report on Friday, December 6th. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of Cooper Companies in a research report on Friday, December 6th. Three research analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. According to MarketBeat.com, Cooper Companies presently has a consensus rating of “Moderate Buy” and a consensus price target of $117.00.

Cooper Companies Stock Performance

Shares of COO stock opened at $93.57 on Monday. The firm has a 50 day moving average of $94.99 and a two-hundred day moving average of $99.85. The stock has a market capitalization of $18.67 billion, a PE ratio of 47.98, a P/E/G ratio of 2.41 and a beta of 1.00. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32. The Cooper Companies, Inc. has a 52 week low of $84.76 and a 52 week high of $112.38.

Cooper Companies (NASDAQ:COO) last released its earnings results on Thursday, December 5th. The medical device company reported $1.04 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.00 by $0.04. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The firm had revenue of $1.02 billion during the quarter, compared to analyst estimates of $1.03 billion. During the same period last year, the business posted $0.87 earnings per share. Cooper Companies’s revenue was up 9.8% compared to the same quarter last year. On average, research analysts predict that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.